Lobe Sciences Ltd. rose 37.5% on Tuesday, October 27, 2026, on 82,000 shares. No headline about LOBE came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Lobe Sciences Ltd. (LOBE:CSE) closed at $0.045 on November 2, 2026, unchanged on the day. The stock trades 75.0% below its 52-week high of $0.180 and 50.0% above its 52-week low of $0.030. Lobe Sciences Ltd. is part of the Life Sciences sector.
In 252 trading sessions since October 30, 2025, LOBE closed higher on 66 days (26%). Its best day was April 30, 2026 (+42.11%) and its worst was October 22, 2026 (-30.00%). The stock moved 10% or more in a single session 73 times. It opened at least 5% above the previous day's high 32 times.
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.
Find more stocks like LOBE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.